M. Lakshman/AP
Are Cord-Blood Banks Exploitive or Essential?
July 24, 2008 9:34 AM
by
findingDulcinea Staff
Whether to save umbilical cord blood in private banks or donate to public repositories is increasingly a crucial decision new parents must make.
30-Second Summary
Private “banks” that preserve umbilical cord blood are aggressively marketing their services to new parents, according to an MSNBC report that raises the concern that parents are being exploited with emotional advertising and misleading information about potential medical problems that the stem cell–rich blood might solve.
“The problem is, the advertising often oversells the potential for cord blood use,” says Dr. Brandon Triplett, medical director of the St. Louis Cord Blood Bank.
Currently, the uses for cord blood stem cells are limited, and only about 2,000 cord blood transplants are performed annually worldwide. A tiny 3 percent of new parents make use of preservation services.
But the cord blood preservation industry is growing; Cord Blood America Inc. announced earlier this month that it continues to increase its inventory in both the United States and in Europe by more than 10 percent annually.
And despite critics’ skepticism about the value of cord blood use, it has in some cases saved lives.
Fox News recently reported that an umbilical cord blood transplant has helped nine-month-old Granton Bayless cope with the immune condition commonly known as “bubble boy” disease.
And Noel Beninati, 58, received cord blood stem cells last May that helped him fight a rare blood condition, reports Time magazine. Parents “must understand the importance this decision can mean for the public good,” Beninati told Time.
Moreover, some doctors say that in the future, cord blood stem cells could help to treat such diseases as certain types of blood cancers, leukemia, sickle-cell anemia, and type-1 diabetes, and could even prove useful in regenerative medicine.
“The problem is, the advertising often oversells the potential for cord blood use,” says Dr. Brandon Triplett, medical director of the St. Louis Cord Blood Bank.
Currently, the uses for cord blood stem cells are limited, and only about 2,000 cord blood transplants are performed annually worldwide. A tiny 3 percent of new parents make use of preservation services.
But the cord blood preservation industry is growing; Cord Blood America Inc. announced earlier this month that it continues to increase its inventory in both the United States and in Europe by more than 10 percent annually.
And despite critics’ skepticism about the value of cord blood use, it has in some cases saved lives.
Fox News recently reported that an umbilical cord blood transplant has helped nine-month-old Granton Bayless cope with the immune condition commonly known as “bubble boy” disease.
And Noel Beninati, 58, received cord blood stem cells last May that helped him fight a rare blood condition, reports Time magazine. Parents “must understand the importance this decision can mean for the public good,” Beninati told Time.
Moreover, some doctors say that in the future, cord blood stem cells could help to treat such diseases as certain types of blood cancers, leukemia, sickle-cell anemia, and type-1 diabetes, and could even prove useful in regenerative medicine.
Headline Link: ‘Cord Blood Choice: Private Fears vs. Public Good
Critics of private cord-blood banks claim that the companies exploit parents by using emotional advertising and exaggerated statistics to scare them into purchasing a service that they’ll probably never need to use.
Source: MSNBC
Background: ‘Creating a Cord Blood Lifeline’
Doctors can now treat at least 70 diseases using stem cells from cord blood, and some state legislators have introduced or passed laws to mandate that doctors and hospitals educate parents about cord-blood donation. In February, Time magazine reported that states such as Oklahoma, Michigan and Arkansas were considering bills to fund the creation of local public cord-blood banks and collection centers.
Source: Time magazine
Related Topics: Missouri baby, Cord Blood America, stem cells used to treat blood disease
A recent umbilical-cord transplant at Children’s Mercy Hospital in Kansas City has turned the formerly frail nine-month-old Granton Bayless into an energetic and friendly baby. Granton has a condition called severe combined immunodeficiency, also known as “bubble boy” disease because it forces many of its victims to live in protective bubbles.
Source: Fox News
Matthew Schissler, the CEO of Cord Blood America, Ind., announced on July 17 that the inventory of the cord-blood preservation company continues to increase, and that it currently houses 20,000 cord-blood stem cell samples.
Source: MarketWatch
The pharmaceutical firm Celgene, the parent company of Life Blood USA—one of the largest cord blood banks in the world—recently announced that human placenta-derived stem cells were used to treat a patient with acute lymphoblastic leukemia, a cancer of the bone marrow and blood.




